-
EP/EC
-
Resolution: Fixed
-
Moderate
-
None
-
Revise logic in future version of the specification so that patients do not calculate in both patient populations.
-
2021; 2022
eCQMs Impacted – CMS145v9/CMS145v10 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
Issue – Measure logic may not restrict patients to a single population if they have both myocardial infarction (MI) within the past 3 years and a current or prior LVEF < 40% (or moderate or severe LVSD), and the LVSDFindings start after the first qualifying encounter and before the end of the second qualifying encounter.
- relates to
-
CQM-4638 CMS145v9 | QRDA III | 2021 Specs
- Closed